Green M - Search Results

1

Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies.

Zhu R, Lu D, Chu YW, Chai A, Green M, Zhang N, Jin JY. Zhu R, et al. Among authors: green m. AAPS J. 2017 May;19(3):669-681. doi: 10.1208/s12248-017-0056-x. Epub 2017 Feb 21. AAPS J. 2017. PMID: 28224402 Review.

2

Meta-analysis of published efficacy and safety data for docetaxel in second-line treatment of patients with advanced non-small-cell lung cancer.

Stroh M, Green M, Cha E, Zhang N, Wada R, Jin J. Stroh M, et al. Among authors: green m. Cancer Chemother Pharmacol. 2016 Mar;77(3):485-94. doi: 10.1007/s00280-015-2957-7. Epub 2016 Jan 12. Cancer Chemother Pharmacol. 2016. PMID: 26758586

3

Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups.

Li J, Lovern M, Green ML, Chiu J, Zhou D, Comisar C, Xiong Y, Hing J, MacPherson M, Wright JG, Riccobene T, Carrothers TJ, Das S. Li J, et al. Among authors: green ml. Clin Transl Sci. 2019 Mar;12(2):151-163. doi: 10.1111/cts.12585. Epub 2018 Sep 28. Clin Transl Sci. 2019. PMID: 30221827 Free PMC article.

4

Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors.

Green ML, Ma SC, Goble S, Giordano H, Maloney L, Simmons AD, Beltman J, Harding TC, Xiao JJ. Green ML, et al. Cancer Chemother Pharmacol. 2022 May;89(5):671-682. doi: 10.1007/s00280-022-04413-7. Epub 2022 Apr 10. Cancer Chemother Pharmacol. 2022. PMID: 35397664

5

Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2.

Konecny GE, Oza AM, Tinker AV, Oaknin A, Shapira-Frommer R, Ray-Coquard I, Aghajanian C, Coleman RL, O'Malley DM, Leary A, Chen LM, Provencher D, Ma L, Brenton JD, Castro C, Green M, Simmons AD, Beltman J, Harding T, Lin KK, Goble S, Maloney L, Kristeleit RS, McNeish IA, Swisher EM, Xiao JJ. Konecny GE, et al. Among authors: green m. Gynecol Oncol. 2021 Jun;161(3):668-675. doi: 10.1016/j.ygyno.2021.03.015. Epub 2021 Mar 19. Gynecol Oncol. 2021. PMID: 33752918 Free PMC article.

6

Model-informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma.

Savic RM, Green ML, Jorga K, Zager M, Washington CB. Savic RM, et al. Among authors: green ml. CPT Pharmacometrics Syst Pharmacol. 2022 Jun;11(6):687-697. doi: 10.1002/psp4.12731. Epub 2022 Apr 21. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35447014 Free PMC article.

7

Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072.

Stroh M, Green M, Millard BL, Apgar JF, Burke JM, Garner W, Lu H, Lyman SK, Desnoyers LR, Richardson J, Hannah A, Kavanaugh WM. Stroh M, et al. Among authors: green m. Clin Pharmacol Ther. 2021 Feb;109(2):383-393. doi: 10.1002/cpt.1985. Epub 2020 Aug 31. Clin Pharmacol Ther. 2021. PMID: 32681519

8

Modeling of Proliferating CD4 and CD8 T-Cell Changes to Tremelimumab Exposure in Patients with Unresectable Hepatocellular Carcinoma.

Song X, Kelley RK, Green M, Standifer N, Lim K, Zhou D, Dunyak J, Negro A, Kurland JF, Ren S, Khan AA, Gibbs M, Abou-Alfa GK. Song X, et al. Among authors: green m. Clin Pharmacol Ther. 2023 Oct;114(4):874-882. doi: 10.1002/cpt.2992. Epub 2023 Jul 28. Clin Pharmacol Ther. 2023. PMID: 37422678

9

Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment.

Preston RA, Marbury T, Balaratnam G, Green M, Dixon S, Lehrer-Graiwer J, Washington C. Preston RA, et al. Among authors: green m. J Clin Pharmacol. 2021 Apr;61(4):493-505. doi: 10.1002/jcph.1757. Epub 2020 Oct 20. J Clin Pharmacol. 2021. PMID: 33084052 Free PMC article. Clinical Trial.

10

Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation.

Salazar DE, Mendell J, Kastrissios H, Green M, Carrothers TJ, Song S, Patel I, Bocanegra TS, Antman EM, Giugliano RP, Kunitada S, Dornseif B, Shi M, Tachibana M, Zhou S, Rohatagi S. Salazar DE, et al. Among authors: green m. Thromb Haemost. 2012 May;107(5):925-36. doi: 10.1160/TH11-08-0566. Epub 2012 Mar 8. Thromb Haemost. 2012. PMID: 22398655 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,920 results

Search Page